MANUEL ABRADELO DE USERA-rekin lankidetzan egindako argitalpenak (24)

2019

  1. Liver Transplantation Using Uncontrolled Donors after Circulatory Death: A 10-year Single-center Experience

    Transplantation, Vol. 103, Núm. 12, pp. 2497-2505

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 695-701

  2. Trasplante hepático como tratamiento de la polineuropatía amiloidótica familiar en pacientes mayores de 60 años

    Medicina Clinica, Vol. 144, Núm. 9, pp. 385-388

2014

  1. Porcine acellular dermal matrix for delayed abdominal wall closure after pediatric liver transplantation

    Pediatric Transplantation, Vol. 18, Núm. 6, pp. 594-598

  2. Renal failure associated with intestinal transplantation: Our experience in Spain

    Transplantation Proceedings

2013

  1. Everolimus monotherapy or combined therapy in liver transplantation: Indications and results

    Transplantation Proceedings

  2. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415

  3. Pregnancy and orthotopic liver transplantation

    Transplantation Proceedings

2012

  1. Liver transplantation from anti-hepatitis C virus-positive donors: Our experience

    Transplantation Proceedings

2011

  1. Switching to sirolimus monotherapy for De Novo tumors after liver transplantation. A preliminary experience

    Hepato-Gastroenterology, Vol. 58, Núm. 105, pp. 115-121

2008

  1. Influence of Dialysis Modality on Complications and Patient and Graft Survival After Pancreas-Kidney Transplantation

    Transplantation Proceedings, Vol. 40, Núm. 9, pp. 2999-3000

  2. Mycophenolate Mofetil Monotherapy in Patients Who Underwent Liver Transplantation for Hepatitis C Cirrhosis

    Transplantation Proceedings, Vol. 40, Núm. 9, pp. 2962-2964

2007

  1. Incidence and risk factors for the development of lung tumors after liver transplantation

    Transplant International, Vol. 20, Núm. 1, pp. 57-63

2006

  1. Incidence of De Novo Nonmelanoma Skin Tumors After Liver Transplantation for Alcoholic and Nonalcoholic Liver Diseases

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2505-2507

  2. Pancreas Preservation With the University of Wisconsin Versus Celsior Solutions

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2582-2584

2005

  1. Hepatic vein reconstruction in living donor liver transplantation

    Transplantation Proceedings

  2. Incidence and risk factors of development of lung tumors after liver transplantation

    Transplantation Proceedings

  3. Incidence of pancreas graft thrombosis in portoiliac and portocaval venous anastomosis

    Transplantation Proceedings